A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

Download the Yahoo Finance app and get personalized finance news, alerts, reviews, statistics, earnings reminders and more. Download the Yahoo Finance mobile app to your phone from the App Store ...